Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 11 04:00PM ET
10.78
Dollar change
+0.23
Percentage change
2.18
%
Index- P/E- EPS (ttm)-2.83 Insider Own0.03% Shs Outstand0.82M Perf Week-1.64%
Market Cap8.84M Forward P/E- EPS next Y-8.39 Insider Trans0.00% Shs Float0.82M Perf Month5.07%
Income4.53M PEG- EPS next Q-1.42 Inst Own0.29% Short Float1.21% Perf Quarter33.91%
Sales0.98M P/S9.02 EPS this Y96.52% Inst Trans-98.86% Short Ratio0.03 Perf Half Y17.81%
Book/sh17.18 P/B0.63 EPS next Y-1341.38% ROA-68.31% Short Interest0.01M Perf Year71.38%
Cash/sh5.15 P/C2.09 EPS next 5Y- ROE-82.60% 52W Range5.00 - 27.90 Perf YTD78.18%
Dividend Est.- P/FCF- EPS past 5Y-16.98% ROI32.10% 52W High-61.36% Beta1.80
Dividend TTM- Quick Ratio4.97 Sales past 5Y-14.72% Gross Margin- 52W Low115.60% ATR (14)0.93
Dividend Ex-Date- Current Ratio4.97 EPS Y/Y TTM115.46% Oper. Margin-811.67% RSI (14)53.06 Volatility10.23% 7.60%
Employees23 Debt/Eq0.00 Sales Y/Y TTM-57.51% Profit Margin463.73% Recom2.50 Target Price30.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q305.57% Payout- Rel Volume0.45 Prev Close10.55
Sales Surprise-42.56% EPS Surprise899.25% Sales Q/Q-81.87% EarningsNov 22 BMO Avg Volume296.54K Price10.78
SMA200.72% SMA504.20% SMA2001.97% Trades Volume132,797 Change2.18%
Date Action Analyst Rating Change Price Target Change
Jul-31-24Upgrade H.C. Wainwright Neutral → Buy $30
Nov-11-24 01:00AM
Sep-30-24 01:00AM
Sep-19-24 01:00AM
Sep-04-24 01:00AM
Aug-27-24 01:00AM
01:00AM Loading…
Jul-22-24 01:00AM
Jul-15-24 01:00AM
Jul-12-24 01:00AM
Jul-01-24 01:00AM
Jun-06-24 07:52AM
01:00AM
Jun-05-24 01:00AM
May-31-24 01:00AM
May-08-24 01:00AM
May-06-24 07:28AM
07:31AM Loading…
Apr-30-24 07:31AM
Apr-29-24 07:33AM
01:00AM
Apr-19-24 01:00AM
Apr-18-24 06:52AM
01:00AM
Apr-11-24 01:00AM
Apr-03-24 01:00AM
Mar-14-24 02:00AM
Jan-31-24 01:00AM
Jan-09-24 01:00AM
Jan-05-24 01:30AM
Dec-20-23 01:00AM
Dec-14-23 01:00AM
Nov-29-23 01:21AM
01:00AM Loading…
01:00AM
Nov-28-23 01:00AM
Nov-23-23 01:00AM
Nov-14-23 01:00AM
Nov-08-23 01:00AM
Nov-02-23 02:00AM
Oct-20-23 01:00AM
Oct-06-23 04:00PM
Oct-05-23 11:20AM
Sep-20-23 01:00AM
Sep-06-23 01:00AM
Sep-05-23 01:00AM
Sep-04-23 01:00AM
Aug-10-23 01:00AM
Aug-04-23 01:00AM
Aug-03-23 01:00AM
Jul-24-23 01:00AM
Jun-15-23 01:00AM
Jun-01-23 01:00AM
May-18-23 01:00AM
May-11-23 01:00AM
May-10-23 01:00AM
May-05-23 01:00AM
May-04-23 01:00AM
Apr-05-23 01:00AM
Apr-04-23 01:00AM
Apr-03-23 01:00AM
Mar-30-23 01:00AM
Mar-28-23 01:00AM
Mar-16-23 02:00AM
Feb-09-23 01:00AM
Feb-06-23 01:00AM
Jan-19-23 01:00AM
Dec-08-22 01:00AM
Nov-11-22 01:00AM
Nov-03-22 02:00AM
02:00AM
Nov-01-22 02:00AM
Sep-20-22 01:00AM
Aug-18-22 01:00AM
Aug-15-22 01:00AM
Aug-12-22 01:00AM
Jul-26-22 04:00PM
Jul-22-22 01:00AM
Jul-21-22 01:00AM
01:00AM
Jun-17-22 01:00AM
May-27-22 01:00AM
May-19-22 01:00AM
May-13-22 01:00AM
May-10-22 01:00AM
May-05-22 01:00AM
Apr-28-22 01:00AM
Apr-25-22 01:00AM
Apr-13-22 01:00AM
Apr-06-22 01:00AM
Mar-31-22 01:00AM
Mar-29-22 12:00PM
Mar-24-22 02:00AM
Mar-10-22 01:10AM
Mar-07-22 01:00AM
Feb-24-22 01:00AM
Feb-15-22 12:00PM
Feb-03-22 01:00AM
Jan-11-22 01:00AM
Jan-06-22 01:00AM
Dec-17-21 01:00AM
Dec-15-21 01:00AM
Nov-18-21 01:00AM
Nov-15-21 01:00AM
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.